Company: STAA
Filing Date: 2025-08-29
Form Type: PREM14A
Source: 0001193125-25-192889
Chunk: 36

Company: STAAR SURGICAL CO
Filing Date: 2025-08-29
Form: PREM14A
Chunk 36
---
 |     | data corruption, cyber-based attacks or network security breaches and/or noncompliance with data protection and 
 privacy regulations;                                                                                            |

| • |     | acquisitions of new technologies; |

| • |     | the willingness of surgeons and patients to adopt a new or improved product and procedure; |

| • |     | extensive clinical trials and resources devoted to research and development; |

| • |     | changes in pricing and pricing controls; |

| • |     | compliance with and changes to applicable laws and regulations, including laws pertaining to healthcare fraud and 
 abuse, and U.S. Food and Drug Administration or international regulations related to product approval; and        |

| • |     | the discretion of regulatory agencies to approve or reject existing, new or improved products, or to require 
 additional actions before or after approval, or to take enforcement action.                                  |

Additional information and detailed discussion of these risks, uncertainties and other potential factors that could affect STAAR’s business and performance and cause actual results or outcomes to differ materially from the results, performance or achievements addressed in STAAR’s forward-looking statements is included in STAAR’s other filings with the SEC, including in the section of this proxy statement titled “ Risk Factors” andsections titled “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” of STAAR’s most recently filed periodic reports on Form 10-Kand Form 10-Qand subsequent filings. STAAR assumes no obligation to update its forward-looking statements, which speak as of their respective dates, whether as a result of new information, future events or otherwise. -22-

RISK FACTORS In addition to the other information included and incorporated by reference into this proxy statement, including the matters addressed in the section entitled “Special Note Regarding Forward-Looking Statements,” you should be aware of and carefully consider the following risks and uncertainties that are applicable to the Merger Agreement, the Merger and STAAR before deciding whether to vote for the Merger Proposal and the Compensation Proposal. You should also consider the risks relating to STAAR’s business and ownership of STAAR common stock contained in the section titled “Risk Factors” in STAAR’s Annual Report on Form 10-Kfor the fiscal year ended December 27, 2024, STAAR’s Quarterly Report on Form 10-Qfor the quarterly period ended June 27, 2025, and in any documents STAAR subsequently files with the SEC, which are incorporated into this proxy statement by reference. See “Where You Can Find